Detalhe da pesquisa
1.
Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial.
J Am Acad Dermatol
; 2024 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38556093
2.
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway.
J Cutan Med Surg
; 27(1_suppl): 3S-24S, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36519621
3.
Phase 2 Trial of Topical Thykamine in Adults With Mild to Moderate Atopic Dermatitis.
J Drugs Dermatol
; 21(10): 1091-1097, 2022 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36219056
4.
Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
Dermatol Ther (Heidelb)
; 14(2): 489-504, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38372938
5.
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor ß antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study.
EClinicalMedicine
; 57: 101826, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36816342
6.
Management of autoimmune skin disorders in the elderly.
Drugs Aging
; 21(12): 767-77, 2004.
Artigo
Inglês
| MEDLINE | ID: mdl-15382957
7.
Clinical management where medicine meets management. More than skin deep.
Health Serv J
; 114(5928): 24-5, 2004 Oct 21.
Artigo
Inglês
| MEDLINE | ID: mdl-15554042
8.
The coexistence of psoriasis and vitiligo: a review.
J Cutan Med Surg
; 16(5): 300-5, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22971303